Hamlet BioPharma AB publ (XSAT:HAMLET B) EPS (Basic): kr-0.31 (TTM As of Mar. 2026)


XSAT:HAMLET B Hamlet BioPharma AB publ XSAT:HAMLET B
31 GF Score
Price kr7.30
! 2 Warning Signs
View Full Analysis

What is Hamlet BioPharma AB publ EPS (Basic)?

Hamlet BioPharma AB publ XSAT:HAMLET B +0.97% 31 EPS (Basic) is kr-0.31 as of Mar. 2026. GuruFocus rates XSAT:HAMLET B with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Hamlet BioPharma AB publ's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was kr-0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.31.

Hamlet BioPharma AB publ's EPS (Diluted) for the three months ended in Mar. 2026 was kr-0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.32.

Hamlet BioPharma AB publ's EPS without NRI for the three months ended in Mar. 2026 was kr-0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -0.32.

During the past 3 years, the average EPS without NRI Growth Rate was 41.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was -30.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hamlet BioPharma AB publ's highest 3-Year average EPS without NRI Growth Rate was 77.90% per year. The lowest was -203.70% per year. And the median was -8.15% per year.

Hamlet BioPharma AB publ  (XSAT:HAMLET B) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hamlet BioPharma AB publ EPS (Basic) Related Terms

Hamlet BioPharma AB publ EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Hamlet BioPharma AB publ's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ EPS (Basic) Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -1.50 -0.18 -0.25 -0.31

Hamlet BioPharma AB publ Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.10 -0.06 -0.08 -0.07
XSAT:HAMLET B
31GF Score
Hamlet BioPharma AB publ XSAT:HAMLET B
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hamlet BioPharma AB publ EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hamlet BioPharma AB publ's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-54.653-0)/177.675
=-0.31

Hamlet BioPharma AB publ's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-12.111-0)/184.662
=-0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of kr-0.31 mean?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a EPS (Basic) of kr-0.31 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Hamlet BioPharma AB publ and its competitors.
Is Hamlet BioPharma AB publ's EPS (Basic) too high?
Hamlet BioPharma AB publ's current EPS (Basic) is kr-0.31. Overall, Hamlet BioPharma AB publ has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Hamlet BioPharma AB publ's EPS (Basic) compare to VRTX and REGN?
Hamlet BioPharma AB publ's EPS (Basic) of kr-0.31 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Hamlet BioPharma AB publ and its competitors. Hamlet BioPharma AB publ's current EPS (Basic) is kr-0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamlet BioPharma AB publ stock overvalued right now?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a current EPS (Basic) of kr-0.31. The current EPS (Basic) is kr-0.31. Hamlet BioPharma AB publ's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Hamlet BioPharma AB publ (XSAT:HAMLET B), the current EPS (Basic) is kr-0.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hamlet BioPharma AB publ Business Description

Other Exchanges 7ZT:Germany
Address Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
31GF Score

Get the complete analysis for XSAT:HAMLET B

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr7.30
Price